Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19?


Şanlıdağ İşbilen G., Aydın Uysal A., Yiğit S., Appak Ö., Sipahi H., Bozdayı G., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, no.54, pp.761-765, 2024 (SCI-Expanded)

  • Publication Type: Article / Article
  • Publication Date: 2024
  • Doi Number: 10.55730/1300-0144.5846
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.761-765
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background/aim: Although seasonal human coronaviruses (HCoVs) have long been recognized as respiratory tract viruses, the newly

identified SARS-CoV-2 caused a pandemic associated with severe respiratory failure. We aimed to evaluate the incidence of COVID-19

infection in patients diagnosed in three tertiary teaching hospitals, both with and without prior confirmed HCoV infection, and to

compare these cohorts in terms of COVID-19 contraction.

Materials and methods: In our study, we examined HCoV PCR-positive cases obtained retrospectively between January 2014 and

March 2020 from three University Hospital Microbiology Laboratories (Cohort 1), as well as PCR-negative patients detected in the same

PCR cycle as the positive cases (Cohort 2). We also evaluated subgroups of HCoV-positive cases.

Results: There was no difference in COVID-19 contraction rates between Cohort 1 and Cohort 2 (p = 0.724). When previous HCoV

subgroups of COVID-19-positive patients were examined, no significant difference was found between the betacoronavirus and

alphacoronavirus subgroups (p = 0.822), among the four groups (NL63, 229E, OC43, HKU-1) (p = 0.207), or between the OC43

subgroup and the other groups (p = 0.295).

Conclusion: Being previously infected with HCoV did not provide protection against COVID-19 in our study group. We suggest

evaluating the possible effect of previous OC43 infection on COVID-19 contraction in larger cohorts.